Daniel C. Koboldt
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
157
Citations
34,909
Est. group size
~18
Recurring co-author estimate
Active years
21
Publishing since 2006
Daniel C. Koboldt's research focuses on identifying and interpreting genetic variants that cause rare neurodevelopmental disorders, congenital heart and craniofacial conditions, and certain cancers, using genome sequencing and functional studies. Much of the work involves discovering new disease genes (such as MARK2, CBX1, EIF3A/EIF3B, and KCNB2) and developing computational methods to better predict which genetic changes are disease-causing. This work is relevant to students interested in human genetics, genomic medicine, and bioinformatics for rare disease diagnosis.
Publication output grew steadily from 2017 to a peak around 2020-2021, then leveled off to a fairly steady pace of roughly 8-10 papers per year through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Disrupted O-GalNAc glycosylation as a mechanism and biomarker of <i>SLC35A2</i> -associated epilepsy
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B
The American Journal of Human Genetics · 2025
- POS0074 TRANSCRIPTOMIC PROFILING OF KIDNEY BIOPSIES IMPLICATES Th17 AND IL-17 IN ANCA-ASSOCIATED GLOMERULONEPHRITIS
Annals of the Rheumatic Diseases · 2025
- De novo variants in ATP2B1 lead to neurodevelopmental delay
The American Journal of Human Genetics · 2025
- A functional role for Septin-2 in the maintenance of the axon initial segment and in human cognitive development
Brain · 2025
- MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway
The American Journal of Human Genetics · 2024
- Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivation
The American Journal of Human Genetics · 2024
- RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS
medRxiv · 2024
- O07: Haploinsufficiency of EIF3A and EIF3B cause a clinically variable phenotype characterized by neurodevelopmental abnormalities and congenital heart defects
Genetics in Medicine Open · 2024
- <i>MARK2</i> variants cause autism spectrum disorder <i>via</i> the downregulation of WNT/β-catenin signaling pathway
medRxiv · 2024
- Dominant-negative variants in CBX1 cause a neurodevelopmental disorder
Genetics in Medicine · 2023
- SNPred outperforms other ensemble-based SNV pathogenicity predictors and elucidates the challenges of using ClinVar for evaluation of variant classification quality
medRxiv · 2023
- Novel inherited<i>CDX2</i>variant segregating in a family with diverse congenital malformations of the genitourinary system
Molecular Case Studies · 2023
- De novo variants in ATP2B1 lead to neurodevelopmental delay
The American Journal of Human Genetics · 2022
- Editorial: From Sequence to Functional Interpretation: Sifting Through the Variation of Genomic Data
Frontiers in Genetics · 2022
- Molecular Case Studies×9
- The American Journal of Human Genetics×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- medRxiv×5
- Molecular Genetics and Metabolism×4
- Marco L. Leung
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Alex H. Wagner
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yassmine Akkari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Mariam Mathew
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kristy Lee
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile